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Abstract
Exposure to both endogenous and exogenous formaldehyde has been established to be 
carcinogenic, likely by virtue of forming nucleic acid and proteins adducts such as N6-
formyllysine. To better assess N6-formyllysine as a biomarker of formaldehyde exposure, we 
studied accumulation of N6-formyllysine adducts in tissues of rats exposed by inhalation to 2 ppm 
[13C2H2]-formaldehyde for 7, 14, 21, and 28 days (6h/day) and investigated adduct loss over a 7-
day post-exposure period using liquid chromatography-coupled tandem mass spectrometry. Our 
results showed formation of exogenous adducts in nasal epithelium and to some extent in trachea, 
but not in distant tissues of lung, bone marrow, or white blood cells, with a 2-fold increase over 
endogenous N6-formyllysine over a 3-week exposure period. Post-exposure analyses indicated a 
bi-exponential decay of N6-formyllysine in proteins extracted from different cellular 
compartments, with half-lives of ~25h and ~182h for the fast and slow phases, respectively, in 
cytoplasmic proteins. These results parallel the behavior of DNA adducts and DNA-protein cross-
links, with protein adducts cleared faster than DNA-protein cross-links, and point to the potential 
utility of N6-formyllysine protein adducts as biomarkers of formaldehyde.
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Introduction
Human exposure to the electrophilic, genotoxic carcinogen formaldehyde (FA) is 
complicated by the presence of both endogenous and exogenous sources. FA is a widespread 
industrial chemical with a global production of over 20 million tons per year and is present 
in a variety of consumer products.1 Moreover, formaldehyde is a naturally occurring cellular 
metabolite and is produced in humans in a variety of endogenous cellular processes.1–3 
Given these environmental and endogenous sources of FA, it is not surprising that humans 
sustain relatively high FA concentrations in plasma, from ~10 to 100 μM.4
FA exposure has long been recognized to have significant health risks due to its toxicity and 
carcinogenicity.1,2,4,5 It is classified as a known human and rodent carcinogen by IARC, 
resulting in nasopharyngeal cancer in humans and nasal squamous cell carcinomas in rats.
1–3
 However, the potential role of inhaled FA in causing leukemia is still a matter of debate 
due to limited evidence from epidemiological studies, the lack of a clear mechanism of 
induction, and the lack of any evidence that inhaled FA even reaches sites distant to the 
portal of entry.1–3,6
To date, a number of rodent and primate studies have investigated potential modes of action 
of FA.1 Its aldehyde moiety readily reacts with nucleophilic sites in proteins and DNA, 
resulting in DNA-protein and DNA-DNA crosslinks as well as a number of DNA and 
protein adducts including N2-hydroxymethyl-dG (N2-HOMe-dG) adducts in DNA3,6 and 
FA-induced Schiff bases on lysine residues of proteins.7 Our recent studies revealed N6-
formyllysine (FLys) as an abundant and stable protein adduct caused by FA exposure.8,9 
FLys formation on cellular proteins, including histones with important epigenetic regulatory 
roles,8,10 and its established association with oxidative and nitrosative stresses of 
inflammation,11,12 suggest that this adduct may play a role in many pathophysiological 
processes in humans.
With FA as the major source of FLys,8,9 we sought to define the contribution of exogenous 
versus endogenous sources of this chemical to the total burden of FLys in cells, using 
[13C2H2]-FA to distinguish exogenous from endogenous contributions.9 An initial in vivo 
study showed a clear concentration-dependent formation of exogenous adducts in nasal 
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epithelium of rats exposed by inhalation to 0.7–9.1 ppm [13C2H2]-FA for 6 h, with 
endogenous adducts dominating even at the highest exposure of 9.1 ppm.9 However, these 
studies did not address longer-term exposures of at lower concentrations more relevant to 
humans. Here, we have investigated the effects of long-term, low-dose inhalation exposure 
to [13C2H2]-FA on the formation, accumulation, and clearance of FLys adducts in different 
tissues in rats.
Materials and Methods
Materials
Lysine internal standard, 4,4,5,5,-[2H]-Lysine, was purchased from Cambridge Isotope 
Laboratories (Andover, MA) and N6-Formyllysine internal standard, 4,4,5,5-[2H]-N6-
formyllysine, was synthesized from 4,4,5,5-[2H]-lysine according to Jiang et al.12 
Streptomyces griseus protease was obtained from Sigma-Aldrich (St. Louis, MO). 
Subcellular Protein Fractionation Kit was purchased from Thermo Scientific (Waltham, 
MA).
Formaldehyde exposure
Fischer 344 rats (6-week old, male) were exposed to [13C2H2]-formaldehyde vapor by 
single-exposure, nose-only inhalation with the final target exposure concentration of 2 ppm 
for 7, 14, 21, and 28 d (6h/d). The exposure was done at the Lovelace Respiratory Research 
Institute (Albuquerque, NM) according to the appropriate and approved protocols for the use 
of vertebrate animals in experiments. For post-exposure studies, the loss of FLys adducts 
after 28 d of exposure was investigated with analyses at 6, 24, 72, and 168 h following 
cessation of FA inhalation. Rats were euthanized using an intraperitoneal barbiturate 
injection at pre-determined time points. Nasal turbinates were collected by splitting the skull 
with a slight bias to one side to preserve septal mucosa. Tissue samples were harvested, 
wrapped in aluminum foil, and immediately snap frozen in liquid nitrogen. They were stored 
at −80 °C pending analyses.
Protein extraction from tissue
Proteins were extracted from tissues as previously described.8 Briefly, ~5–10 mg of nasal 
epithelium, trachea, lung, or bone marrow was cut into small pieces and washed with PBS. 
Tissues were then homogenized (in cytoplasmic extraction buffer of Subcellular Protein 
Fractionation Kit) using a Kontes all-glass Dounce homogenizer with 5 strokes of a type A 
pestle followed by 10 strokes of a type B pestle. Proteins from WBC were also extracted in a 
similar fashion. For total protein extraction, cell lysate was centrifuged at 14000 × g for 15 
min at 4 °C and supernatant collected. To further examine exogenous and endogenous 
adduct distribution in different cellular compartments, proteins extracted from nasal 
epithelium were further separated into cytoplasmic, membrane, soluble nuclear, and 
chromatin bound fractions using Subcellular Protein Fractionation Kit. Proteins in each 
fraction were precipitated by adding 20% v/v trichloroacetic acid followed by overnight 
incubation at 4 °C. Samples were centrifuged at 14000 × g for 10 min at 4 °C, washed with 
ice-cold acetone (once with acetic acetone containing 0.1% HCl and once more with 
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acetone), air-dried and kept at −20 º C pending analyses. N6-Formyllysine was found to be 
stable under these conditions.
Enzymatic hydrolysis of proteins
Protein were hydrolyzed into single amino acids as described previously.8 Briefly, extracted 
proteins were dissolved in 50 μL of 100 mM ammonium bicarbonate buffer (pH 8.5). 
Enzymatic digestion was done by adding 2 μl of freshly prepared Streptomyces griseus 
protease solution (1μg/μl) and incubating at 37 °C for ≥16 h. 2 nmol 4,4,5,5-[2H]-lysine and 
1pmol 4,4,5,5-[2H]-N6-formyllysine internal standards were added prior to enzymatic 
digestion. Using our methods, samples generally yielded 20–100 μg of protein for which we 
had confirmed complete proteolysis using 2 μg of Streptomyces griseus (based on control 
studies of theoretical versus measured lysine levels of commercial histone proteins). 
Regardless, the difference in protein quantities among samples was corrected for by 
normalizing the quantity of FLys to the quantity of lysine in each analysis. Samples were 
vacuum dried and resuspended in 50 μL of water prior to mass spectrometry analysis. 
Typically 1 μL of prepared protein hydrolysates was injected per analysis.
N6-Formyllysine quantification
Using sensitive and specific liquid chromatography-coupled mass spectrometry (LC-
MS/MS) methods, N6-formyllysine was quantified as a percentage of lysine as described 
previously.8 Analytes in each sample were first HPLC separated (Agilent 1100 series 
system) using an aqueous normal-phase Cogent diamond hydride column (2.1 × 150 mm, 4 
μm particle size) from MicroSolv Technology Corporation (Eatontown, NJ). The solvent 
systems were 0.1% acetic acid in water (A) and 0.1% acetic acid in acetonitrile (B), with a 
flow rate of 400 μL/min and a temperature of 20 °C. With the elution starting at 100% B, the 
gradient linearly decreased to 75% B over 75 min, reaching 25% B by 78 min, and 15% B 
by 83 min before re-equilibration with 100% B for 7 min. Mass spectrometry detection and 
quantification of FLys and lysine were done using Agilent 6410 triple quadrupole mass 
spectrometer equipped with an electrospray ionization (ESI) source operated in positive ion 
mode. ESI capillary voltage was set to 4000 V, gas temperature to 350 °C, nebulizer pressure 
to 30 psi, and drying gas flow to 12 L/min. Selected reaction monitoring (SRM) transitions 
were m/z 175→112 for endogenous FLys (neutral loss of H2O, CO, and NH3 with an 
intramolecular rearrangement), m/z 177→114 for exogenous FLys, and m/z 179→116 for 
FLys internal standard (Figure 1). As shown in Figure 1, there is another peak with similar 
transition as exogenous FLys (m/z 177→114) that elutes ~57.5min. It is identified as the [M
+1] ion of citrulline and has no association with exogenous formaldehyde.8 Lysine and 
lysine internal standard were monitored with transitions m/z 147→130 (neutral loss of 
NH3), and m/z 151→134, respectively. The fragmentor voltage and collision energies were 
105 V and 10 V for FLys and 100 V and 8 V for lysine, respectively. The limits of detection 
for lysine and FLys were 10 and 1 fmol, respectively.
Results
Endogenous FLys was detectable in all tissues analyzed, with levels ranging from 1 to 9 
adducts per 104 lysines depending on the tissue type (Table 1). The endogenous levels in 
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each tissue were similar across all time points of FA exposure (Table 1), indicating that 
exogenous FA did not alter the endogenous adduct levels. This is consistent with previous 
studies at higher FA doses.9 There were significant differences in FLys levels among the 
tissues (WBC ≪ nasal < bone < lung < trachea; Table 1), possibly due to different levels of 
endogenous FA production. To further examine FLys adduct distribution in different cellular 
compartments, proteins extracted from nasal epithelium were further resolved into 
cytoplasmic, membrane, and nuclear proteins. Data showed that the endogenous FLys levels 
were similar among the various cellular compartments (Tables S1 and S2, Supporting 
Information), which suggests that endogenously-generated FA is freely accessible to all 
cellular compartments. This differs for exposure to exogenous FA, as discussed next.
Unlike FLys derived from endogenous FA, the levels of FLys caused by exposure to 
exogenous FA were only detected in nasal epithelium and to some extent in trachea (Table 2, 
Table S3, Supporting Information), with endogenous FLys ~3- to 18-fold and ~60- to 130-
fold higher then exogenous levels, respectively, in total proteins. Exogenous FLys showed a 
trend toward accumulation over the 4-week exposure period, increasing ~2-fold from day 7 
to day 28 (Figure 2, Table 2). However, this trend was not statistically significant (e.g., 
p=0.055 for total proteins).
In tissues distant from the upper airway (lung, bone marrow, white blood cells), FA exposure 
did not produce a detectable increase in exogenous FLys beyond the natural isotope 
abundance level of ~0.7%, corresponding to [M+2] ion of FLys (Table 2, Table S3, 
Supporting Information). This suggests that inhaled FA is mostly absorbed in the nasal 
passages before reaching distant sites. Intracellular compartments accessibility trend, with 
exogenous Flys levels generally 2- to 3-fold lower in chromatin (with histones as the major 
proteins) than other compartments (Figure 2, Table S1, Supporting Information). For 
example, on Day 28 of FA exposure, there were 0.4 exogenous FLys adducts per 104 lysines 
in chromatin compared to 1.1 residues in cytoplasmic or membrane fractions (p < 0.05). 
This could be due to reaction of FA with biomolecules as it enters the cell before it reaches 
the nucleus. These compartment biases are likely not a result of differential removal or 
repair mechanisms since endogenous FLys levels are similar in all compartments.
To assess the decay of FLys in FA-exposed tissues, we quantified FLys levels in tissues and 
subcellular compartments at 6, 24, 72 and 168 h after 28 d of FA exposure (Table 2; Tables 
S2, S3, Supporting Information). In all cases, there was a bi-exponential decay pattern for 
FLys levels, with an initial rapid loss over 24 h (t1/2 of ~18–34 h) followed by a slower 
decay (t1/2 of ~ 151–186 h) over the next 6 d (Figure 3; Figure S1, Supporting Information).
Discussion
A parallel investigation of FA-induced N2-hydroxymethyl-dG (N2-HOMe-dG) and DNA-
protein cross-links in the same study group revealed strong correlations between the DNA 
damage13,14 and FLys. Similar to exogenous FLys, exogenous N2-HOMe-dG and DNA-
protein cross-links showed formation and accumulation in nasal epithelium and not in 
tissues distant to the site of initial contact.13,14 Furthermore, similar to FLys, the exogenous 
N2-HOMe-dG adducts and DNA-protein cross-links occurred at lower levels than 
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endogenous species (~2- to 7- fold) at all exposure time points. However, while FLys and 
N2-HOMe-dG exhibited a measurable late elimination half-life (151–186 h and 170 h, 
respectively), the DNA-protein cross-links persisted at relatively high levels beyond 7 d 
post-exposure.14
These differences in formation and clearance of FA adducts provide insights into the 
molecular basis of FA toxicity and carcinogenicity. The consistent observation of FA-
induced protein and nucleic acid adducts only in the most immediately exposed tissues, and 
not at sites distant to the portal of entry (e.g., bone marrow), raises questions about the 
proposed link between inhaled FA and leukemia.1,2,4 At the same time, the diversity of FA-
induced molecular damage both complicates and reinforces conclusions about mode of 
action of FA as a carcinogen. For example, FLys formation at conserved sites of lysine 
acetylation and methylation in histone proteins,10 the chemical similarity of FLys and lysine 
N6-acetylation,8 and the resistance of FLys adducts to removal by histone deacetylases8 all 
suggest that FLys could interfere with histone-based epigenetics15 as one potential 
mechanism of toxicity and carcinogenesis. Such epigenetic effects could combine with the 
direct genotoxicity of FA-induced DNA adducts and DNA-protein cross-links as well as 
indirect genotoxicity of mutagenesis associated with FA-induced cell death, to cause 
mutations and cancer.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Accumulation of exogenous N6-formyllysine adducts in total protein extracted from nasal 
epithelium of rats exposed to [13C2H2]-formaldehyde by inhalation. The use of [13C2H2]-
formaldehyde allows for differentiation of exogenous from endogenous adducts. The three 
isotopomeric species monitored by LC-MS/MS. Endogenous, exogenous, and internal 
standard 4,4,5,5-[2H]-FLys were monitored by LC-MS/MS using transitions of m/z 
175→112, m/z 177→114, and m/z 179→116, respectively.
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Figure 2. 
Accumulation and loss of exogenous FLys adducts. Ratios of exogenous vs. endogenous 
FLys in the nasal epithelium of rats exposed by inhalation to 2 ppm [13C2H2]-FA for 7, 14, 
21, and 28 days (6h/day). Data represent mean ± SD for n=4.
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Figure 3. 
Example of the bi-exponential decay of exogenous FLys adducts. Exogenous FLys were 
quantified in cytoplasmic proteins extracted from nasal epithelium of rats at various times 
following a 28-day inhalation exposure to 2 ppm [13C2H2]-FA (6h/d). Data show an initial 
rapid loss over 24 h (t1/2 of ~25 h) followed by a slower decay (t1/2 of ~182 h) over the next 
6 d. Data represent mean ± SD for n=4.
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